107 results on '"Maehr H"'
Search Results
2. ChemInform Abstract: Synthesis of a Biologically Active Vitamin-D2 Metabolite (I).
3. ChemInform Abstract: A Convergent Synthesis of Ro24-5913, a Novel Leukotriene D4 Antagonist.
4. Selective vitamin D receptor modulators and their effects on colorectal tumor growth
5. Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs
6. Antibiotics: Elfamycins
7. Elfamycins
8. ChemInform Abstract: Syntheses of the Anti‐AIDS Drug 2′,3′‐Dideoxycytidine (I) from Cytidine.
9. ChemInform Abstract: A Tribute to the Centennial of the Fischer Projection. Display of Alkene Geometry and Axial Stereogenicity
10. Calcitriol Derivatives with Two Different Side Chains at C-20. II. Diastereoselective Syntheses of the Metabolically Produced 24(R)-Hydroxygemini<SUP>1</SUP>
11. Graphic Representation of Configuration in Two-Dimensional Space. Current Conventions, Clarifications, and Proposed Extensions<SUP>1,2</SUP>
12. Structure optimization of a leukotriene D~4 antagonist by combinatorial chemistry in solution
13. Combinatodal chemistry in drug research from a new vantage point
14. Separation of gentamicin C-complex into five components by Craig distribution
15. ChemInform Abstract: SUBSTITUTED PYRIMIDINES. II. 1,3‐DIMETHYLISOCYTOSINE AND RELATED COMPOUNDS
16. ChemInform Abstract: MICROBIAL PRODUCTS. 5. ABSOLUTE CONFIGURATION OF AMINOGLYCOSIDE X-14847
17. Antimetabolites produced by microorganisms. XIV. 2-Methyl-L-arginine, a new amino acid with antibiotic properties.
18. Antimetabolites produced by microorganisms. XV. Synthesis of 2-methyl-L-arginine, 2-methyl-L-ornithine and their enantiomers.
19. Antibiotic X-5108. IX. Chemical conversion of mocimycin to aurodox and derivatives of aurodox, goldinamine and mocimycin.
20. Microbial products. VII. The relative configuration of actinomycete metabolite X-14881D.
21. ChemInform Abstract: TOTAL SYNTHESES OF RIVULARINS D1 AND D3
22. ChemInform Abstract: MICROBIAL PRODUCTS. II. GRANATICINIC ACID, A NEW ANTIBIOTIC FROM A THERMOPHILIC STREPTOMYCETE
23. ChemInform Abstract: RIVULARINS. PRELIMINARY SYNTHETIC STUDIES
24. ChemInform Abstract: Synthetic (S)‐5‐(Benzoyloxy)‐6‐oxohexanoic Acid Ethyl Ester and ((S,S)‐E)‐3‐(Hydroxymethyl)oxiranebutanoic Acid Methyl Ester, Important Synthons for Leukotrienes B4 and A4, from D‐Arabinose.
25. ChemInform Abstract: ANTIMETABOLITES PRODUCED BY MICROORGANISMS PART 9, CHEMICAL SYNTHESIS OF N(5)‐HYDROXYORNITHINE AND N(5)‐HYDROXYARGININE
26. ChemInform Abstract: A NEW APPROACH TO 4-SUBSTITUTED INDOLES
27. ChemInform Abstract: Practical Applications of the Craig Distribution. Part 1
28. ChemInform Abstract: N,N-((4-NITRO-1H-INDEN-1-YLIDENE)METHYL)DIALKYLAMINES BY AN UNEXPECTED REACTION
29. ChemInform Abstract: ANTIBIOTICA UND ANDERE NATUERLICH VORKOMMENDE HYDROXAMSAEUREN UND HYDROXAMSAEUREESTER
30. ChemInform Abstract: SUBSTITUIERTE PYRIMIDINE 1. MITT. N(4)‐SUBSTITUIERTE 1,3‐DIALKYLCYTOSINE
31. ChemInform Abstract: A Convergent Synthesis of Ro24-5913, a Novel Leukotriene D4 Antagonist.
32. ChemInform Abstract: Synthesis of a Biologically Active Vitamin-D2 Metabolite (I).
33. Analysis of the Transcriptome: Regulation of Cancer Stemness in Breast Ductal Carcinoma In Situ by Vitamin D Compounds.
34. Vitamin D compounds inhibit cancer stem-like cells and induce differentiation in triple negative breast cancer.
35. Structural analysis and biological activities of BXL0124, a gemini analog of vitamin D.
36. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer.
37. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
38. Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.
39. Oral administration of a gemini vitamin D analog, a synthetic triterpenoid and the combination prevents mammary tumorigenesis driven by ErbB2 overexpression.
40. Diastereotopic and deuterium effects in gemini.
41. Targeting CD44-STAT3 signaling by Gemini vitamin D analog leads to inhibition of invasion in basal-like breast cancer.
42. A novel Gemini vitamin D analog represses the expression of a stem cell marker CD44 in breast cancer.
43. Structure-function study of gemini derivatives with two different side chains at C-20, Gemini-0072 and Gemini-0097.
44. Gemini vitamin D analog suppresses ErbB2-positive mammary tumor growth via inhibition of ErbB2/AKT/ERK signaling.
45. Calcitriol derivatives with two different side chains at C-20. V. Potent inhibitors of mammary carcinogenesis and inducers of leukemia differentiation.
46. Synthesis and anti-inflammatory properties of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-24-oxo-vitamin D3, a hypocalcemic, stable metabolite of 1alpha,25-dihydroxy-16-ene-20-cyclopropyl-vitamin D3.
47. Novel Gemini vitamin D(3) analogs have potent antitumor activity.
48. Gemini vitamin D analogues inhibit estrogen receptor-positive and estrogen receptor-negative mammary tumorigenesis without hypercalcemic toxicity.
49. Activation of bone morphogenetic protein signaling by a Gemini vitamin D3 analogue is mediated by Ras/protein kinase C alpha.
50. Calcitriol derivatives with two different side-chains at C-20. Part 4: further chain modifications that alter VDR-dependent monocytic differentiation potency in human leukemia cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.